pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
PATH · news · pharmadog
← back to PATH
News mentioning PATH
466
stories
9d
PepGen soars on promising early data for muscular dystrophy drug
biopharma dive
9d
Oura to acquire AI virtual primary care partner Counsel Health for $625M
fiercebiotech
9d
Bayer wins first-in-class FDA nod for blood thinner, setting stage for BMS-J&J rival
biospace
9d
Why this year’s flu season could be hitting teens and young adults hard
stat
9d
STAT+: State Democratic wins make Medicaid expansion a possibility for more than a million people
stat
9d
London startup raises $60M for degraders aimed at Alzheimer’s protein tau
endpoints
9d
Coherus shrinks headcount 30% to narrow focus of cancer combo
fiercebiotech
10d
Heron sells assets to CorMedix for $145M upfront; Faeth's stock tumbles
endpoints
10d
Details from Novartis’ failed cardiovascular trial offer ‘little silver lining’ for rivals
biospace
10d
Novo’s troubled cardio drug could find niche in less sick patients
biospace
10d
Translating Phase II success into Phase III readiness takes more than scale
biopharma dive
10d
AI chatbots aren’t therapists. But can they finally get men to open up?
stat
10d
Before GMP: Six manufacturing considerations gene therapy sponsors should address earlier
biospace
10d
Valneva sees LimmaTech vaccine reduce Shigella infections in phase 2 test
fiercebiotech
10d
FDA slashes number of analytical tests for IVDs used in public health emergencies
raps
13d
Moderna enjoys stable vaccine sales thanks to global COVID uptake
biospace
13d
Sarepta’s new CEO confident in clinical execution as DMD competitors close in
biospace
13d
There's more than one way to build a biotech
fiercebiotech
13d
When China Fits a Global Clinical Development Strategy
fiercebiotech
14d
Coveted metabolic gem Rhythm reportedly gets $10B offer from AstraZeneca
biospace
14d
Evommune signs $1B deal with China’s Hinova to enter same molecular glue niche as Novartis
fiercebiotech
15d
AbbVie bets up to $1.47B for Nxera’s discarded IBD program
biospace
15d
Sanofi ends development of Nurix's STAT6 degrader
endpoints
15d
Top health takeaways from the midterm elections
stat
15d
How a Ms. Frizzle-esque librarian helped Flagship’s Louisa Helms find biotech
biospace
15d
Ultragenyx shrinks workforce and axes assets to halve R&D spend
fiercebiotech
15d
6 potential blockbusters that could pave China’s path to 2030 ambitions
biospace
16d
UniQure gets an FDA decision date; Teva scraps brain drug study
biopharma dive
16d
Advanced Analytics Help Reduce Control Animal Use While Preserving Scientific Rigor
fiercebiotech
17d
FDA peptide policy risks undermining drug development and patient safety
biospace
← prev
page 2 of 16
next →